Indirect treatment comparison of bevacizumab + interferon-&alpha;-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

Indirect treatment comparison of bevacizumab + interferon-&alpha;-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

Gerald HJ Mickisch1, Bj&ouml;rn Schwander2, Bernard Escudier3, Joaquim Bellmunt4, Jos&eacute; P Maroto5, Camillo Porta6, Stefan Walzer7, Uwe Siebert8,91Department of Urology, Center of Operative Urology Bremen, Bremen, Germany; 2Department of Outcomes Research, AiM GmbH Assessment-in...

Full description

Bibliographic Details
Main Authors:	Gerald HJ Mickisch, Bj&ouml;rn Schwander, Bernard Escudier, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-01-01
Series:	ClinicoEconomics and Outcomes Research
Online Access:	http://www.dovepress.com/indirect-treatment-comparison-of-bevacizumab--interferon-alpha-2a-vs-t-a6126

Similar Items

Risk factors for the development of depression in patients with hepatitis C taking interferon-&alpha;
by: Smith KJ, et al.
Published: (2011-05-01)

Targeted therapies in the management of renal cell carcinoma: role of bevacizumab
by: Bernard Escudier, et al.
Published: (2008-09-01)

&nbsp;&alpha;-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studies
by: Shityakov S, et al.
Published: (2012-06-01)

Review of consensus interferon in the treatment of chronic hepatitis C
by: Th Witth&ouml;ft
Published: (2008-09-01)

Update and developments in the treatment of glioblastoma multiforme &ndash; focus on bevacizumab
by: Naveed Wagle, et al.
Published: (2010-06-01)

Residential mobility among foreign-born persons living in Sweden is associated with lower mortality
by: Bj&ouml;rn Albin, et al.
Published: (2010-07-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
by: Maria Dimou, et al.
Published: (2014-01-01)

Bilateral horizontal Vogt&rsquo;s striae in keratoconus
by: Inci Ulu G&uuml;ng&ouml;r, et al.
Published: (2008-10-01)

Bevacizumab (Avastin&reg;) for the management of anterior chamber neovascularization and neovascular glaucoma
by: Dimitrios Brouzas, et al.
Published: (2009-11-01)

Parkinson&rsquo;s disease patients&rsquo; subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
by: Skogar &Ouml;, et al.
Published: (2012-10-01)

Long-term pegylated interferon-&alpha; and its potential in the treatment of melanoma
by: Reinhard Dummer, et al.
Published: (2009-04-01)

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors
by: Sylvie Négrier, et al.
Published: (2017-08-01)

Do neurologists in Germany adhere to the national Parkinson&#39;s disease guideline?
by: Sabrina Schr&ouml;der, et al.
Published: (2011-03-01)

Volunteering in dementia care &ndash; a Norwegian phenomenological study
by: S&ouml;derhamn U, et al.
Published: (2012-02-01)

Lack of information and access to advanced treatment for Parkinson&rsquo;s disease patients
by: L&ouml;kk J
Published: (2011-12-01)

Bevacizumab in the therapy for refractory metastatic colorectal cancer
by: Mary F Mulcahy
Published: (2008-03-01)

An update on the toxicity of A&beta; in Alzheimer&rsquo;s disease
by: J&uuml;rgen G&ouml;tz, et al.
Published: (2008-12-01)

Recent achievements in the management of Raynaud&rsquo;s phenomenon
by: Magnus Baumh&auml;kel, et al.
Published: (2010-03-01)

Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors
by: Christian U. Blank, et al.
Published: (2021-12-01)

Amphiphilic poly{[&alpha;-maleic anhydride-&omega;-methoxypoly(ethylene glycol)]-co-(ethyl cyanoacrylate)} graft copolymer nanoparticles as carriers for transdermal drug delivery
by: Jinfeng Xing, et al.
Published: (2009-10-01)

Pharmacokinetics of intravitreal bevacizumab (Avastin&reg;) in rabbits
by: Sinapis C, et al.
Published: (2011-05-01)

Is monthly retreatment with intravitreal bevacizumab (Avastin&reg;) necessary in neovascular age-related macular degeneration?
by: Nicola G Ghazi, et al.
Published: (2010-04-01)

Gastrointestinal perforation associated with bevacizumab in metastatic colorectal cancer
by: Kunpeng Fang, et al.
Published: (2024-02-01)

Bevacizumab in metastatic breast cancer: when may it be used?
by: Shari B. Goldfarb, et al.
Published: (2011-03-01)

Schwannoma response to interferon alpha
by: Jennifer Novak, et al.
Published: (2017-12-01)

L-Tyrosine-loaded nanoparticles increase the antitumoral activity of direct electric current in a metastatic melanoma cell model
by: V&acirc;nia Emerich Bucco de Campos, et al.
Published: (2010-11-01)

ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro
by: Skoglund K, et al.
Published: (2013-08-01)

Diurnal salivary cortisol concentrations in Parkinson&rsquo;s disease: increased total secretion and morning cortisol concentrations
by: Skogar &Ouml;, et al.
Published: (2011-08-01)

Proteins from Avastin® (bevacizumab) show tyrosine nitrations for which the consequences are completely unclear.
by: Jia Wan, et al.
Published: (2012-01-01)

Clinical case use bevacizumab for patient with metastatic ovarian cancer
by: M. R. Oganyan, et al.
Published: (2014-07-01)

CLINICAL EXPERIENCE OF PROLONGED BEVACIZUMAB THERAPY IN METASTATIC COLORECTAL CANCER
by: I. S. Bulavina, et al.
Published: (2015-02-01)

Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumab
by: Ronald M Bukowski
Published: (2010-03-01)

Tumor necrosis factor alpha as a marker of systemic and local inflammation in &ldquo;healthy&rdquo; smokers
by: Juan M Diez-Pina, et al.
Published: (2009-02-01)

Hypertension and angiotensin system inhibitors in patients with metastatic renal cell carcinoma
by: Lisa Derosa, et al.
Published: (2016-11-01)

Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab bevacizumab alone in women with newly diagnosed advanced ovarian cancer
by: Robert Hettle, et al.
Published: (2021-09-01)

Production of alpha-interferon in Lactococcus lactis
by: Bayat, Omid
Published: (2013)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
by: Megen C. Wittling, et al.
Published: (2021-01-01)

Surgical and nonsurgical treatment of total rupture of the pectoralis major muscle in athletes: update and critical appraisal
by: J&ouml;rn Kircher, et al.
Published: (2010-10-01)

Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.
by: Jubb, A, et al.
Published: (2011)

Pharmacogenetics in Model-Based Optimization of Bevacizumab Therapy for Metastatic Colorectal Cancer
by: Apostolos Papachristos, et al.
Published: (2020-05-01)